Head of US Marketing

Waltham, Massachusetts, United States

Apply with AI Apply

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Pharmaceuticals, HealthcareIndustries

Requirements

The Head of US Marketing should be an experienced and hands-on leader with strong strategic planning capabilities. They must be adept at defining US brand strategy across HCP and Patient communities in neuromuscular disease, ensuring effective and aligned cross-functional implementation. The role requires seamless collaboration with Field roles, Medical Affairs, Patient Services, Advocacy, and Market Access to ensure cohesive go-to-market strategies and successful execution. This is a key role on the US leadership team, based in Waltham, MA.

Responsibilities

The Head of US Marketing will develop differentiated marketing strategies, including digital and omnichannel engagement tactics, and implement initial brand plans for the US. They will lead the development and execution of integrated cross-functional brand plans in partnership with the above-market team, and coordinate tactics with global reach such as Congresses, KOL engagement, education, and awareness initiatives. Responsibilities also include partnering with Medical Affairs to build HCP-level brand advocacy and adoption, ensuring integration of Patient Advocacy, and driving innovation in commercial strategy to build brand awareness and intent to prescribe. The role involves working closely with Insights & Analytics to support message testing and market research, instilling a metrics-driven mindset, and ensuring compliance with legal and governance standards for all commercial activities. Additionally, they will lead coordination and execution of launch planning for DMD and DM1, developing launch strategies, core messages, and integrated cross-functional launch plans, including critical educational, promotional, and Patient Advocacy activities.

Skills

Marketing Strategy

Brand Strategy

Digital Marketing

Omnichannel Marketing

HCP Marketing

Patient Marketing

Launch Strategy

Cross-functional Collaboration

Leadership

Strategic Planning

Commercial Strategy

Dyno Therapeutics

Develops AI-optimized gene therapy vectors

About Dyno Therapeutics

Dyno Therapeutics focuses on advancing gene therapy by utilizing Artificial Intelligence to create Adeno-associated virus (AAV) vectors. These vectors are essential tools for delivering genetic material into cells, which is crucial for effective gene therapy. The company's AI technology enables the design and optimization of these vectors, potentially enhancing the success of gene therapies. Dyno collaborates with major pharmaceutical and biotech companies, such as Astellas, Roche, Sarepta, and Novartis, to develop therapies for various diseases affecting the skeletal and cardiac muscles, central nervous system, liver, and eyes. Unlike many competitors, Dyno's unique approach leverages AI to improve the performance of AAV vectors, setting it apart in the biotech field. The company's goal is to improve gene therapy outcomes through its advanced vector technology, ultimately benefiting patients with serious health conditions.

Watertown, MassachusettsHeadquarters

2018Year Founded

$106MTotal Funding

SERIES_ACompany Stage

AI & Machine Learning, Biotechnology, HealthcareIndustries

51-200Employees

Benefits

Remote Work Options

Risks

Gene therapy investment slowdown may impact Dyno's growth and innovation.

Manufacturing bottlenecks could hinder scaling of Dyno's operations.

Increased competition from companies like Form Bio challenges Dyno's market position.

Differentiation

Dyno uses AI to design optimized AAV vectors for gene therapy.

Their AI-driven CapsidMap platform enhances AAV vector development for muscle gene therapies.

Partnerships with major pharma companies like Astellas and Roche boost Dyno's market presence.

Upsides

AI-driven capsid design improves delivery efficiency and reduces manufacturing costs.

Collaboration with NVIDIA enhances biological sequence design for gene therapies.

Generative AI increases efficiency of eye and brain-targeted capsid delivery significantly.

Land your dream remote job 3x faster with AI

Try Jobo Free